Chronic non-communicable diseases (NCDs) like cancer, cardiovascular diseases, chronic respiratory diseases, diabetes and mental illnesses are the leading causes of disease burden and mortality around the world, across all country income levels. According to the World Health Organization (WHO), NCDs were responsible for at least 43 million deaths in 2021, with 18 million people dying from an NCD before the age of 70. Of these premature deaths, 82% occurred in low- and middle-income countries (LMIC).
The FIP practice transformation programme (PTP) on NCDs is a flagship project that aims to deliver FIP’s commitment to the WHO’s Astana Declaration and to the primary healthcare agenda, with a focus on non-communicable diseases.
Aim
The FIP PTP on NCDs aims to provide tools and strategic support to FIP member organisations to develop and implement pharmacy services that can have a sustained positive impact in the prevention, screening, management, and treatment optimisation of NCDs for improved patient outcomes and health systems efficiency and sustainability.
While the project will have a particular focus on low-and-middle-income countries, it will encourage implementation by countries of all income levels, since the goals of optimising NCDs management and reducing the burden of these diseases are a global imperative.
Vision
The vision of the programme is to promote the global transformation of pharmacy practice and the quality improvement of services delivered to improve health outcomes and the quality of life of individuals living with NCDs.
Mission
The mission of the programme is to:
- Assist FIP member organisations in assessing their country’s needs for pharmacy services that address the burden of NCDs.
- Provide guidance for the training and education of pharmacists, transforming the way they provide NCDs-related pharmacy services.
- Support FIP member organisations and individual pharmacists in the implementation of pharmacy services and programmes that can reduce the burden of NCDs.
